The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
SPAR: A randomized placebo-controlled phase 2 trial of simvastatin in addition to standard chemotherapy and radiation in preoperative treatment for rectal cancer: An AGITG clinical trial.
 
Michael B. Jameson
Research Funding - Bayer (Inst); BeiGene (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Exelixis (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); HUYA Bioscience International (Inst); Merck (Inst); MSD Oncology (Inst); Pfizer (Inst); Roche (Inst); Sabinsa Corporation (Inst); Sanofi (Inst)
 
Kirsten Gormly
No Relationships to Disclose
 
David Espinoza
No Relationships to Disclose
 
Wendy Hague
No Relationships to Disclose
 
Grahame Mark Jeffery
No Relationships to Disclose
 
Timothy Jay Price
Honoraria - SERVIER
Consulting or Advisory Role - Amgen (Inst); AstraZeneca (Inst); BMS (Inst); Merck
Research Funding - AMGEN (Inst)
Travel, Accommodations, Expenses - Amgen
 
Christos Stelios Karapetis
No Relationships to Disclose
 
Michael Arendse
No Relationships to Disclose
 
James Armstrong
No Relationships to Disclose
 
John Childs
No Relationships to Disclose
 
Frank Frizelle
No Relationships to Disclose
 
Samuel Y Ngan
No Relationships to Disclose
 
Andrew Stevenson
Research Funding - Intuitive Surgical
 
Rix Du Plessis
No Relationships to Disclose
 
Swetha Sridharan
No Relationships to Disclose
 
Matthew E. Burge
Stock and Other Ownership Interests - Bristol-Myers Squibb; coclear; CSL Limited; Gilead Sciences; pfizer
Honoraria - Amgen; Bristol Myers squibb; Merck KGaA; Merck Sharp & Dohme; SERVIER
Consulting or Advisory Role - Amgen; ipsen; merck srpe Dohme; Roche; SERVIER
Speakers' Bureau - Merck Sharpe Dohme
Research Funding - Amgen (Inst)
Patents, Royalties, Other Intellectual Property - funding for an investigator initiated prospective trial (Inst)
 
Stephen P. Ackland
Expert Testimony - Merck; Merck; Sharpe